• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Claudio Bordignon - Articles and news items

MolMed strengthens top management team with the appointment of Germano Carganico as General Manager

Industry news, News / 24 November 2010 / MolMed S.p.A.

MolMed S.p.A. is pleased to announce the strengthening of its top management…

Stem cell research and therapeutic innovation: not always a long-term perspective

Industry Focus 2009, Past issues / 10 January 2009 /

When talking about stem cell research and its contribution to medical innovation, distinction should be made between embryonic stem cell research, believed to have almost infinite potential but with quite long-term perspectives, and adult stem cell research, which is already offering new therapeutic applications for otherwise incurable diseases. Today, adult stem cell-based therapies are in clinical development for a wide range of disorders1, and this field has indeed great potential to fill the gap in the market and help a large patient population with otherwise untreatable diseases. This is also generating an evolution in the regulatory framework2, as well as the issue of guidelines for responsible transition of stem cell research into appropriate clinical applications3, as witnessed by the very recent initiatives of the European Commission and of the International Society for Stem Cell Research.

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +